✦ LIBER ✦

Rifaximin for Hepatic Encephalopathy

✍ Scribed by Moye, P. M.; Yunker, N. S.

Book ID: 125544352
Publisher: SAGE Publications
Year: 2009
Tongue: English
Weight: 431 KB
Volume: 25
Category: Article
ISSN: 8755-1225
DOI: 10.1177/875512250902500207

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rifaximin for Treatment of Hepatic Encep

Rifaximin for Treatment of Hepatic Encephalopathy

✍ Maclayton, D. O; Eaton-Maxwell, A. 📂 Article 📅 2008 🏛 Harvey Whitney Books Company 🌐 English ⚖ 149 KB

Rifaximin Treatment in Hepatic Encephalo

Rifaximin Treatment in Hepatic Encephalopathy

✍ Bass, Nathan M.; Mullen, Kevin D.; Sanyal, Arun; Poordad, Fred; Neff, Guy; Leevy 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 420 KB

Rifaximin effectively prevents hepatic e

Rifaximin effectively prevents hepatic encephalopathy

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Rifaximin for the Treatment of Hepatic E

Rifaximin for the Treatment of Hepatic Encephalopathy

✍ Dr. Kenneth R. Lawrence; Dr. Jacqueline A. Klee 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Rifaximin for the Treatment of Hepatic E

Rifaximin for the Treatment of Hepatic Encephalopathy

✍ P.S. Mantry; S. Munsaf 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 458 KB

Gut instinct: Rifaximin for the preventi

Gut instinct: Rifaximin for the prevention of hepatic encephalopathy

✍ Asma Siddique; Kris Kowdley 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

BACKGROUND: Nonalcoholic steatohepatitis is a common liver disease that can progress to cirrhosis. Currently, there is no established treatment for this disease. METHODS: We randomly assigned 247 adults with nonalcoholic steatohepatitis and without diabetes to receive pioglitazone at a dose of 30 mg